Chartwell Investment Partners’s Integra LifeSciences IART Stock Holding History

Chartwell Investment Partners’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-48,625	Closed	-$3.2M	–	454
2018 Q3	$3.2M	Buy	48,625 +62	+0.1%	+$3.85K	0.09%	293
2018 Q2	$3.13M	Sell	48,563 -1,699	-3%	-$105K	0.09%	290
2018 Q1	$2.78M	Sell	50,262 -885	-2%	-$46.4K	0.1%	247
2017 Q4	$2.45M	Sell	51,147 -39,478	-44%	-$1.93M	0.08%	297
2017 Q3	$4.57M	Buy	90,625 +48,599	+116%	+$2.5M	0.16%	200
2017 Q2	$2.29M	Buy	+42,026	New	+$2.01M	0.09%	272

Other funds holding IART

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Chartwell Investment Partners's IART Position: Q4 2018 in Review

Chartwell Investment Partners sold out of Integra LifeSciences (IART) in Q4 2018, closing a stake of 48,625 shares — an estimated $3.2M sold.

Chartwell Investment Partners first reported a position in IART in Q2 2017 and held it in 6 quarters. The position peaked at $4.57M in Q3 2017. 248 funds tracked by Wall St. Rank hold IART as of Q4 2018.

Chartwell Investment Partners reported no remaining Integra LifeSciences position as of Q4 2018 after selling out during the quarter.
Chartwell Investment Partners sold 48,625 Integra LifeSciences shares in Q4 2018, an estimated $3.2M.
Chartwell Investment Partners first reported a position in Integra LifeSciences in Q2 2017 and held it in 6 quarters.
Chartwell Investment Partners's Integra LifeSciences position peaked at $4.57M in Q3 2017.
248 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2018.

Based on Chartwell Investment Partners's 13F filing for Q4 2018, filed 1 Feb 2019.